Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1971;45(3):275–278.

Meningococcal infections*

1. Prevalence of serogroups causing disease in US Army personnel in 1964-70

Malcolm S Artenstein, Herman Schneider, Martha D Tingley
PMCID: PMC2427927  PMID: 5004110

Abstract

Examination of large numbers of strains of meningococci associated with systemic disease in US Army personnel over a 7-year period has shown a changing pattern of sero-group prevalence and an increasing proportion of sulfadiazine-resistant organisms. These findings underline the failure of sulfadiazine prophylaxis and the necessity of applying a specific vaccine to this population. Knowledge of this kind from other populations will be required in order to provide appropriate control measures—vaccine or chemoprophylaxis.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYCOCK W. L., MUELLER J. H. Meningococcus carrier rates and meningitis incidence. Bacteriol Rev. 1950 Jun;14(2):115–160. doi: 10.1128/br.14.2.115-160.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander C. E., Sanborn W. R., Cherriere G., Crocker W. H., Jr, Ewald P. E., Kay C. R. Sulfadiazine-resistant group A Neisseria meningitidis. Science. 1968 Sep 6;161(3845):1019–1019. doi: 10.1126/science.161.3845.1019. [DOI] [PubMed] [Google Scholar]
  3. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  4. Artenstein M. S., Rust J. H., Jr, Hunter D. H., Lamson T. H., Buescher E. L. Acute respiratory disease and meningococcal infection in army recruits. JAMA. 1967 Sep 25;201(13):1004–1007. [PubMed] [Google Scholar]
  5. Bennet J. V., Young L. S. Trends in meningococcal disease. J Infect Dis. 1969 Nov;120(5):634–635. doi: 10.1093/infdis/120.5.634. [DOI] [PubMed] [Google Scholar]
  6. Evans J. R., Artenstein M. S., Hunter D. H. Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol. 1968 May;87(3):643–646. doi: 10.1093/oxfordjournals.aje.a120854. [DOI] [PubMed] [Google Scholar]
  7. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med. 1969 Jun 1;129(6):1385–1395. doi: 10.1084/jem.129.6.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MILLAR J. W., SIESS E. E., FELDMAN H. A., SILVERMAN C., FRANK P. IN VIVO AND IN VITRO RESISTANCE TO SULFADIAZINE IN STRAINS OF NEISSERIA MENINGITIDIS. JAMA. 1963 Oct 12;186:139–141. doi: 10.1001/jama.1963.63710020008016. [DOI] [PubMed] [Google Scholar]
  10. Sanders E., Deal W. B. Prevention of meningococcal infections. J Infect Dis. 1970 Apr;121(4):449–451. doi: 10.1093/infdis/121.4.449. [DOI] [PubMed] [Google Scholar]
  11. Vandekerkove M., Causse G., Lapeyssonnie L., Faucon R. Sensibilité aux sulfamides des méningocoques du sérotype A. Bull World Health Organ. 1969;41(6):843–850. [PMC free article] [PubMed] [Google Scholar]
  12. Vassiliadis P., Kanellakis A., Papadakis J. Sulphadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece. J Hyg (Lond) 1969 Jun;67(2):279–288. doi: 10.1017/s0022172400041681. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES